School of Medicine
  • Print
   
   
 
Over 80% of our research was judged to be ‘world leading’ or ‘internationally excellent’ in the Research Excellence Framework (REF) 2014.
 

Impact

Our research activity has impact in three major areas:

  1. Translational research bridges key gaps between invention, evaluation and adoption, driving significant changes in medical practice and clinical guidelines.
  2. Our ambitious patient engagement programmes link researchers with patients and the public from early research stages identifying important questions to advanced stages of adoption of research findings.
  3. Our commercial collaborations are accelerating the pace of drug and treatment development. We are working with firms in the UK and internationally, creating successful spin-out companies and transforming intellectual property into valuable innovations.
 

Video highlight

A clinical trial into the treatment of the severe blistering skin condition ‘bullous pemphigoid’ has found that starting treatment with an oral antibiotic is an effective and safer alternative to the current standard  treatment of oral steroids which can have harmful long-term side effects. 

The study was led by skin experts at the Centre of Evidence Based Dermatology. The results of the NIHR-funded BLISTER trial are published in The Lancet. 

 

 

 

School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Please see our 'contact us' page for further details